INTRODUCTION
It has been demonstrated in the late 1930s and early 1940s that oestradiol and its esters induce tumors in guinea pigs and mice (IARC, 1987) . Since that time, numerous data concerning tumor induction by oestrogens have been accumulated, and various rodent tumor models have been introduced (IARC, 1999) . Besides, epidemiological studies pointed to an increased risk of breast and uterine tumors in women treated with oestrogens (Liehr, 2001 ).
Oestrogens can promote tumor growth due to receptor-mediated stimulation of mitotic divisions (Platet et al., 2004) . However, since oestrogens exhibited genotoxic effects in various systems in vitro and in vivo (Liehr and Roy, 1990 ; Rajapakse et al., 2005) , it is clear that they actually act as carcinogens capable not only to stimulate mitosis (tumor promotors), but also to elevate the mutation rate in susceptible cells (tumor initiators). These findings shed a new light on the analysis of the relevance of hormones in malignant transformations.
Biochemical and molecular biological analysis provided an insight into the mechanisms of malignant transformations caused by oestrogens. Induction of kidney tumors in hamsters chronically exposed to oestrogens represents one of the most useful models for examination of carcinogenic effects of oestrogens and related compounds (Papa et al., 2003) . It has been shown that a low picogram range of oestrogen concentrations causes normal physiological responses in the target tissues. However, at elevated doses oestrogens induce tumors in laboratory animals (kidney tumor in Syrian hamsters, uterine tumors in mice etc.) (Krikman, 1959; Walker, 1983) . Likewise, it has been clearly demonstrated that synthetic nonsteroidal oestrogen diethylstilbestrol (DES) exhibits carcinogenic properties (IARC, 1979) .
At elevated concentrations of oestrogens, metabolic reactions which lead to the formation of free radicals may become the predominant biochemical activity, thus overshadowing their hormonal effects. Since oestrogens are phenols, the metabolism of their phenolic moiety, while harmless at low oestrogen tissue levels, may exert deleterious effects at high concentrations (Liehr and Roy, 1990; Cavalieri and Rogan, 2004) . The first step in redox cycling of oestrogens is their enzymatic conversion to catecholoestrogens (Liehr and Roy, 1990 ). Catecholoestrogens and diethylstilbestrol posses a catechol group so they can be involved in a redox cycling which create conditions of oxidative stress accompanied by covalent damage of macromolecules including DNA (Cavalieri et al., 2000) . In the kidney, which is a target organ of oestrogen-induced carcinogenesis, estrogens induce both DNA adducts (Liehr et al., 1991) and chromosome alterations (gaps, breaks and endoreduplicated cells) (Banerjee et al., 1994) .
In our previous studies we demonstrated that 17b-oestradiol induces sisterchromatid exchanges (Djeli} and Djeli}, 2002) and micronuclei (Djeli} et al., 2005) in cultured human lymphocytes. These results are in accordance with findings of genotoxic effects of natural (Ahmad et al., 2000) and synthetic oestrogens (Hundal et al., 1997) 
in human lymphocytes in vitro.
Bearing in mind all the above mentioned, the objectives of the present study were to examine the mitotic activity, cell cycle kinetics and the appearance of chromosome aberrations in cultured human lymphocytes exposed to 17b-oestradiol. Experimental concentrations of oestradiol were calculated to correspond to a wide range of concentrations in human blood; i.e physiological level, therapeutic range and up to 30 fold maximal therapeutic concentration for humans. This investigation should contribute to a better understanding of genetic risk under a wide range of oestradiol concentrations. In vitro cytogenetic test. Two hours before harvesting colcemid (0.5 mg/ml) (Ciba, Basel, Switzerland) was added to the cultures. Hypotonic condition was achieved by 0.075 M KCl. After three standard cycles of fixation in methanol-acetic acid (3:1, v/v), cell suspension was dropped on chilled grease-free microscopic slides, air dried and stained in 10% Giemsa (Kemika, Zagreb, Croatia). For each experimental concentration, as well as the for the controls, 150 mitotic plates were examined on coded slides. Scoring of gaps and breaks was performed according to the established criteria (Brogger, 1982) . Mitotic index (MI) was calculated as percentage of cells in mitosis on a count of at least 2000 cells.
Cell cycle kinetics. In order to distinguish between cells in the first, second and third mitotic division, 5-bromo-2'-deoxyuridine (BrdUrd, Chemical Co., St. Louis, MO) was added to cultures one hour after the addition of PHA in order to prevent possible competition for the same binding sites at cell membranes. Treatment and harvest of mitosis were performed the same way as described in the cytogenetic test. After at least 2 days of ageing, metaphase spreads were stained by Fluorescence-plus-Giemsa (FPG) method (Perry and Wolff, 1974) . The calculation of cell proliferation index was achieved using the formula CPI = (M 1 + 2M 2 + 3M 3 )/100, where M 1 , M 2 and M 3 represent the percentage of cells in the first, second and third mitosis, respectively. For each donor, at least 200 metaphases were scored for CPI calcualtion.
Statistical analysis. Statistical analysis of cytogenetic data was performed by Student's t-test. Cell cycle kinetics data were analysed by c 2 test. The differences with P £ 0.05 value were considered as significant.
RESULTS
The obtained results of mitotic indices are presented in Table 1 . The percentage of cells in mitosis was lowered by 33.7% in cultures treated with the positive control (MNNG) compared to the negative control (the solvent, DMSO). Evidently, only the positive control caused a significant (P<0.01) decrease of MI compared to the negative control. Treatment with oestradiol has caused insignificant changes from the control values (P>0.05). The percentage of cells in mitosis in oestradiol-treated cultures ranged from 4.08% to 6.48%. The cell cycle kinetics was evaluated by cell proliferation index (CPI), a parameter that represents the ratio of cells in the first, second and third mitosis ( Table 2 ). Since the chromosomes were stained according to FPG procedure it was possible to clearly distinguish cells in the first, second and third mitotic cycle. The difference between chromosomes in the first and second mitosis is showed on Fig. 1 . Obviously, in the first mitosis both chromatids are darkly stained, whereas in the second one chromatid is darkly and another sister chromatid is lightly stained. The analysis of CPI revealed no significant differences in the cell cycle kinetics after the treatment with oestradiol. In cultures treated with positive control the CPI value is lowered by 15.9% compared to the negative control (P<0.01). and polyploidies (P<0.05). Experimental oestradiol concentration of 10 -10 M comparable with the physiological level of oestradiol in women, was not capable to cause significant changes of the frequency of cells with cytogenetic changes (aneuploidies, polyploideis and chromosome gaps and breaks). Likewise, at a higher concentration (10 -9 M), as well as concentrations corresponding to minimal (7x10 -8 M) and average (3.5x10 -6 M) therapeutic dose, the results on cytogenetic assessment of genotoxic effects of oestradiol were negative. Treatment with oestradiol was efficient in the induction of gaps and breaks and aneuploidies at the three highest concentrations used (7x10 -6 M, 7x10 -5 M and 2.1x10 -4 M) which correspond to the maximal therapeutic dose in human medicine, 10 fold and 30 fold "maximal therapeutic" doses, respectively. Thus, at a concentration of 7x10 -6 M we noticed 5.3-fold increase of gaps and breaks and 2.6-fold increase in aneuploidies. Experimental concentration of 7x10 -5 M elevated the frequency of cells with gaps and breaks 5-fold, and frequency of cells with aneuploidies 3.4-fold. Finally, the highest concentration of oestradiol (2.1x10 -4 M) caused 6-fold increase of gaps and breaks ( Fig. 2 ) and 3.8-fold increase of aneuploidies. Chromosome breaks were also analysed separately form gaps (Tab. 4). In addition to the positive control which caused a significant increase of breaks (P <0.01), only the highest concentration of oestradiol had increased the frequency of cells with breaks (P<0.05). Finally, it should be emphasized that oestradiol had no effect on the frequency of polyploid cells. As expected, the well-known mutagen MNNG used as a positive control caused a significant (P<0.05) increase of the frequency of polyploid lymphocytes (Fig. 3) . Investigations of the effects of endogenous mutagenic agents are complex due to the simple fact that endogenous substances are normally present in animal and human bodies. Therefore, it is unlikely to expect that natural selection during the process of evolution would have allowed the presence of substances capable of disturbing the genetic integrity. On the other hand, a low level of mutations is compatible with survival, and may contribute to changes of the genetic structure of a population, which is important for the long-term evolution process.
Hormones represent one of the best studied group of endogenous mutagens (Djeli} and Djeli}, 2002) . In the present study, we studied the cell cycle kinetics and cytogenetic changes in cultured human lymphocytes exposed to seven experimental concentrations of oestradiol in a range from 10 -10 M to 2.1 x 10 -4 M. Our data shows that oestradiol at 7x10 -6 M ("maximal therapeutic dose") and two higher concentrations (7x10 -5 M and 2.1x10 -4 M) exhibits aneugenic and clastogenic effects. Aneugenic effects imply chromosome lagging during mitosis which leads to aneuploidy. Our results of aneugenic effects are in accordance with the findings which demonstrate the induction of aneuploidies in human and mouse fibroblasts (Tsutsui et al., 1990) . It is conceivable that oestadiol induces aneuploidy through mitotic arrest, rather than inhibition of microtubule assembly in vitro (Wheeler et al., 1987) .
Clastogenic effects imply DNA damage accompanied by chromosome breakage. In the positive control the well known alkylating agent (MNNG) was an efficient (P<0.001) inducer of gaps and breaks. The three highest concentrations of oestradiol used in this experiment exhibited clastogenic effects. According to modern standpoint phenolic groups of steroidal oestrogens, especially at elevated tissue concentrations, are converted to catecholestrogens which can be inculded in redox cycling (Cavalieri and Rogan, 2004) . Reactive oxygen species and semiquinones created during the redox cycling of phenolic groups in steroidal or nonsteroidal oestrogens can induce DNA adducts (Rizzati et al., 2005) including 8-hydroxydeoxyguanosine (Liehr, 2000) . Incomplete repair of this chemically modified base may lead to creation of DNA breakage which underlies chromosome breakage. Interestingly, in addition to hormonal activity, both natural and synthetic oestrogens containing phenolic structures can have pro-oxidant and/or antioxidant effects depending primarily on their tissue concentrations and presence of metal cations (Liehr and Roy, 1998) . In the presence of redox-active metal ions high tissue concentrations of catechol oestrogens exhibit pro-oxidant effects. These effects are evident through oxygen free radical-mediated toxicity such as single-strand DNA breaks, lipid peroxidation, 8-hydroxylation of guanine bases of DNA and chromosomal abnormalities (Liehr and Roy, 1998) . Therefore, it is conceivable that high experimental concentrations of oestradiol used in this investigation created oxidative stress and oxidative radical DNA damage. This assumption is supported by experimental findings showing that the DNA damaging effects of oestradiol in single cell gel electrophoresis (Comet) assay were reduced by the antioxidant enzyme catalase both in human lymphocytes (Djeli} and Anderson, 2003) and sperm . Some of these not completely reparable lesions induced by oestrogen in our investigation, were converted into gaps and/or breaks. These chromosome lesions are a precondition for the formation of structural chromosome aberrations (inversions, translocations and other chromosome rearrangements) (Savage, 2004) . However, in this experiments we have not observed any structural chromosome aberrations. Probably, clastogenic effects of high oestradiol concentrations were not high enough to create structural chromosome changes. It is generally acknowledged that unlike ionizing radiation, chemical mutagens (including hormones), as a rule, are not strong inducers of chromosome breakage and structural aberrations (Tucker et al., 2005) . On the other hand, oestradiol has not influenced the frequency of polyploid lymphocytes. Only the positive control (MNNG) caused a significant (p<0.05) increase of the frequency of polyploid cells, possibly interfering in the function of mitotic spindle microtubules (Tsuiki et al., 2001) .
To determine the possible cytotoxic, cytostatic or mitogenic effects of oestradiol we analysed the mitotic index (MI) for each experimental concentration, as well as for the controls. In order to avoid possible changes in mitotic activity we used the same quality media and PHA for all experimental cycles. After stimulation of peripheral blood lymphocytes with PHA, the cultures soon contained different generations of cells, i.e. cells that have divided for a different number of times. The heterogeneity of cell division reflects either a difference in the cell cycle duration, or a difference in the times when the cells started blastogenesis in response to PHA (Wheeler et al., 1987) . Obviously, oestradiol has not influenced mitotic activity of human lymphocytes compared to the negative control and untreated cultures. Moreover, cell proliferation index (CPI) as a parameter indicating cell cycle progression has not changed in oestradiol-treated cultures. Therefore, oestradiol has not exhibited stimulatory or inhibitory effects on mitotic activity and cell cycle kinetics under the described experimental conditions. As expected, the positive control (MNNG) decreased MI by ¬34% and CPI by 16 .5% compared to the negative control, possibly due to an arrest of mitosis due to repair of genetic material. Cytotoxic effects occur in cells with a relatively high level of genetic damage (Sordo et al., 2001 ).
In conclusion, since oestardiol caused some cytogenetic damage we assume that oestradiol use may pose genetic risk at cytogenetic level, especially at high doses, or if used as a therapy over a prolonged period of time. On the other hand, there was no modulatory effect of oestradiol on human lymphocyte proliferation in vitro.
